Expands Branded Product Portfolio and Develops New Markets for Gastrointestinal and Respiratory Products
Jacobson Pharma Announces FY2019 Interim Results
Profit from Operations Leapt by 40.7% to HK$158.6 Million. Declares Interim Dividend of HK1.5 cents per share. Growth Strategies to Tap Innovative Pharma Market and Expand Regional Presence